Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients

Haris Ali(City of Hope), Monzr M. Al Malki(Johns Hopkins Hospital), Sanjeet Dadwal(City Of Hope National Medical Center), Shukaib Arslan, Guido Marcucci(The Ohio State University), Jason Chen(City of Hope), Dat Ngo(City of Hope), Ahmed Aribi, Ryotaro Nakamura(City of Hope), Stephen J. Forman(City Of Hope National Medical Center)
Transplantation and Cellular Therapy
July 15, 2021
10.1016/j.jtct.2021.07.008
Cited by 78

Related Papers

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k